MedicaidCoverageMedium impact
Genomic and Molecular Biomarker Testing for Cancer - MEDICAID - INDIANA (New)
Humana·IN · Oncology, Hematology, Genetics·Medicaid
Effective date
Apr 8, 2026
We identified it
Jun 24, 2026
Summary
New Humana Medicaid policy in Indiana establishes that specific concurrent DNA/RNA genetic testing for cancer (including +RNAinsight tests) are NOT covered services. All listed genomic and molecular biomarker tests have coverage limitations with insufficient evidence for standard medical treatment.
Action Required
Before April 8, 2026: Billing team must update system to flag CPT codes 0133U, 0157U, 0159U, 0160U, 0161U, and 0162U as non-covered for Humana Medicaid Indiana members. Update encounter forms to alert providers that concurrent DNA/RNA genetic testing for cancer is not covered. Claims for these services will be denied.